Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2

Status: Completed
Location: See all (10) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The Archimedes System is an image-guided navigation system used to access tissue samples in the lungs. This study is being conducted to confirm the performance of the Archimedes System in patients who are scheduled for standard bronchoscopy to diagnose highly suspicious lung cancer or metastatic disease. Navigation to and sampling of the patient's lung cancer tumor is conducted.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 80
Healthy Volunteers: f
View:

• Age 21-75 years at screening

• Highly suspicious pulmonary nodule(s), defined as distinct nodule with a diameter of ≥8mm in its largest dimension

• No known endobronchial tumor

• Tumor located anywhere in parenchymal tissue \>1 cm from pleura and accessible bronchoscopically through a POE.

• Willing to participate in all aspects of study protocol for duration of study

• Able to understand study requirements

• Subject or legally authorized representative signs study-related informed consent document

Locations
United States
Massachusetts
Beth Israel Deaconess Medical Center
Boston
North Carolina
Duke University
Durham
Oklahoma
Cancer Treatment Centers of America at Southwestern Regional Medical Center
Tulsa
Pennsylvania
Temple University Hospital
Philadelphia
University of Pennsylvania
Philadelphia
Texas
Houston Methodist Hospital
Houston
Other Locations
China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou
Shanghai Chest Hospital
Shanghai
Germany
ThoraxKlinik
Heidelberg
Hong Kong Special Administrative Region
Hong Kong Sanatorium & Hospital
Hong Kong
Time Frame
Start Date: 2016-08
Completion Date: 2018-12
Participants
Target number of participants: 166
Treatments
Experimental: -Navigation and tissue sampling
Guided bronchoscopic navigation and lung tissue sampling using the Archimedes System
Related Therapeutic Areas
Sponsors
Leads: Broncus Medical Inc

This content was sourced from clinicaltrials.gov